Unity Biotechnology Upgraded - Analyst Highlights Cash Stren

Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution

Wedbush analyst Andreas Argyrides upgraded the shares of Unity Biotechnology Inc UBX from Neutral to Outperform and raised the price target from $2 to $4.…

Related Keywords

Andreas Argyrides , Unity Biotechnology Inc , News , Ggregator , Reaking News , Uration , Media ,